← All trials
NCT06356012
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 2, 2024
- Primary completion
- Dec 31, 2026
- Completion date
- Dec 31, 2028
- First posted
- Apr 10, 2024
- Last posted
- Apr 10, 2024
- Enrollment
- 96
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Barretos Cancer HospitalLead sponsor
- Hospital de Cancer de Barretos - Fundacao Pio XIICollaborator
- Fundação de Amparo à Pesquisa do Estado de São PauloCollaborator
- Farmoquimica S.A.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.